Spyre Therapeutics (SYRE) Prepaid Assets (2015 - 2026)

Spyre Therapeutics has reported Prepaid Assets for 12 years, with the latest figure at $22.5 million in Q1 2026.

• For the quarter ending Q1 2026, Prepaid Assets rose 354.45% year-over-year to $22.5 million; the trailing twelve-month figure through Mar 2026 stood at $22.5 million (up 354.45% YoY), and the FY2025 full-year result was $21.2 million, up 294.5% from the prior year.
• Prepaid Assets for Q1 2026 stood at $22.5 million, up from $21.2 million in the prior quarter.
• The five-year high for Prepaid Assets was $22.5 million in Q1 2026, with the low at $2.2 million in Q3 2023.
• Historically, Prepaid Assets has averaged $8.4 million across 5 years, with a median of $6.2 million in 2022.
• Annual changes were most pronounced in 2023 — Prepaid Assets plunged 72.23% — and 2026, when it soared 354.45%.
• Spyre Therapeutics' Prepaid Assets stood at $6.2 million in 2022, then slumped by 63.53% to $2.3 million in 2023, then jumped by 139.27% to $5.4 million in 2024, then surged by 294.5% to $21.2 million in 2025, then grew by 5.83% to $22.5 million in 2026.
• The last three Prepaid Assets figures came in at $22.5 million (Q1 2026), $21.2 million (Q4 2025), and $18.4 million (Q3 2025), per Business Quant data.